Jeffrey Wang

Jeffrey Wang is Professor of Biotechnology and Pharmaceutical Sciences and Associate Dean for Research and Global Advancement at Western University of Health Sciences' College of Pharmacy. He holds a PhD in Pharmaceutical Sciences from University of Southern California (1995) and B.S. in Pharmacy from Shanghai Medical University (1986). His research focuses on drug delivery systems, prodrug design, and nanotechnology applications in pharmaceuticals.

Key research areas include reversible lipidization of biomolecules, oral peptide delivery, and nanoparticle formulation development. He has led/co-led numerous grants including NIH-funded studies on pancreatic cancer nanotherapy (2014-2017) and chemoresistance mechanisms (2016-2017). Notable achievements include 4 patents related to drug delivery innovations and over 10 peer-reviewed publications in journals like Drug Delivery and Translational Research and Nanoscale.

Recent work emphasizes synergistic drug combinations (e.g., loratadine-SMEDDS/sulforaphane for pancreatic cancer) and silk fibroin nanoparticle systems. His educational contributions include curriculum development for pharmacokinetics courses. Current projects involve preclinical development of factor IX-based hemophilia therapies and novel formulations for antibiotics like vancomycin.

• Key grants: NIH R15 (pancreatic cancer nanotherapy), Strategic Drug Solutions (nasal spray bioavailability study)
• Labs/Teams: Collaborates with Eureka BioVenture on silkworm drug models and Novo Nordisk on hemophilia B therapies